Review Article
Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
Table 2
Effects of BBR on inflammatory cytokines and inflammation in cultured cells or animals with diabetes mellitus or insulin resistance.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
: decrease, : increase; BBR: berberine, LPS: lipopolysaccharide, KM mice: Kunming mice, HFD: high fat diet, STZ: streptozotocin, NAFLD: nonalcoholic fatty liver disease, p.o.: per os/oral administration, i.p.: intraperitoneal, TNF-: tumor necrosis factor-, IL: interleukin, CRP: C-reaction protein, HP: haptoglobin, MMP9: matrix metalloprotease 9, COX2: cyclooxygenase-2, iNOS: inducible nitric oxide synthase, MCP-1: monocyte chemoattractant protein 1, ICAM-1: intercellular adhesionmolecule-1, TGF-1: transforming growth factor-1, IFN: interferon-. |